TheProfitWatch

OLMA - Olema Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
22.19 0.67 (3.02%) 0.02 (0.11%) -0.03 (-0.13%) 0.71 (3.21%) -0.91 (-4.1%) 1.37 (6.38%) 0.44 (2.03%) -0.35 (-1.62%)

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.51
Diluted EPS:
-0.51
Basic P/E:
-44.8235
Diluted P/E:
-44.8235
RSI(14) 1m:
68.18
VWAP:
22.84
RVol:

Events

Period Kind Movement Occurred At

Related News